Patents by Inventor Helge Zieler

Helge Zieler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230076421
    Abstract: The present disclosure provides compositions and methods for polynucleotide synthesis in vitro, specifically the use of single-subunit RNA polymerases for synthesis and manufacturing of RNA.
    Type: Application
    Filed: May 23, 2020
    Publication date: March 9, 2023
    Inventors: Dongxin Karen XU, Kadir Chir TUNG, Sabrina BAFFERT, Alan GREENER, Helge ZIELER
  • Patent number: 11198708
    Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to obtain desirable phenotypic changes that modulate tolerance to stress, thus creating novel characteristics of the transformed organism.
    Type: Grant
    Filed: February 9, 2020
    Date of Patent: December 14, 2021
    Assignee: Primordial Genetics, Inc.
    Inventors: Helge Zieler, Sabrina German, Animesh Ray, Biranchi Narayan Patra
  • Publication number: 20210324439
    Abstract: Provided herein include methods of making mogroside compounds, e.g., Compound 1, compositions (for example host cells) for making the mogroside compounds, and the mogroside compounds made by the methods disclosed herein, and compositions (for example, cell lysates) and recombinant cells comprising the mogroside compounds (e.g., Compound 1). Also provided herein are novel cucurbitadienol synthases and the use thereof.
    Type: Application
    Filed: June 23, 2021
    Publication date: October 21, 2021
    Inventors: Andrew P. Patron, Chris Edano Noriega, Rama R. Manam, Justin Colquitt, Nathan Faber, Helge Zieler, Justin Stege
  • Patent number: 11060124
    Abstract: Provided herein include methods of making mogroside compounds, e.g., Compound 1, compositions (for example host cells) for making the mogroside compounds, and the mogroside compounds made by the methods disclosed herein, and compositions (for example, cell lysates) and recombinant cells comprising the mogroside compounds (e.g., Compound 1). Also provided herein are novel cucurbitadienol synthases and the use thereof.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: July 13, 2021
    Assignee: Firmenich Incorporated
    Inventors: Andrew P. Patron, Chris Edano Noriega, Rama R. Manam, Justin Colquitt, Nathan Faber, Helge Zieler, Justin Stege
  • Publication number: 20200270315
    Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to obtain desirable phenotypic changes that modulate tolerance to stress, thus creating novel characteristics of the transformed organism.
    Type: Application
    Filed: February 9, 2020
    Publication date: August 27, 2020
    Inventors: Helge ZIELER, Sabrina GERMAN, Animesh RAY, Biranchi Narayan PATRA
  • Patent number: 10556935
    Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to obtain desirable phenotypic changes that modulate tolerance to stress, thus creating novel characteristics of the transformed organism.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: February 11, 2020
    Assignee: PRIMORDIAL GENETICS INC.
    Inventors: Helge Zieler, Sabrina German, Animesh Ray, Biranchi Narayan Patra
  • Publication number: 20190071705
    Abstract: Provided herein include methods of making mogroside compounds, e.g., Compound 1, compositions (for example host cells) for making the mogroside compounds, and the mogroside compounds made by the methods disclosed herein, and compositions (for example, cell lysates) and recombinant cells comprising the mogroside compounds (e.g., Compound 1). Also provided herein are novel cucurbitadienol synthases and the use thereof.
    Type: Application
    Filed: May 2, 2018
    Publication date: March 7, 2019
    Inventors: Andrew P. Patron, Chris Edano Noriega, Rama R. Manam, Justin Colquitt, Nathan Faber, Helge Zieler, Justin Stege
  • Publication number: 20190002873
    Abstract: The present invention relates to compositions involving randomized in-frame fusion polynucleotides and their introduction into a host organism to identify desirable phenotypic changes. The present invention further relates to methods of generating these randomized in-frame fusion polynucleotides by introducing randomized in-frame fusion polynucleotides into an organism, selecting for organisms with new or altered phenotypes, re-isolating the randomized in-frame fusion polynucleotides from the selected organisms, re-assembling the constituent polynucleotides of the re-isolated randomized in-frame fusion polynucleotides into new collections of randomized in-frame fusion polynucleotides, and repeating the selection for organisms with new or altered phenotypes.
    Type: Application
    Filed: September 14, 2018
    Publication date: January 3, 2019
    Inventor: Helge ZIELER
  • Patent number: 10093922
    Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to identify desirable phenotypic changes that disrupt or alter existing genetic or biochemical mechanisms or pathways, thus creating novel characteristics of the transformed organism. Methods for using the compositions for increasing diversity within populations of organisms are also presented.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: October 9, 2018
    Inventor: Helge Zieler
  • Patent number: 10077441
    Abstract: The present invention relates to compositions involving randomized in-frame fusion polynucleotides and their introduction into a host organism to identify desirable phenotypic changes. The present invention further relates to methods of generating these randomized in-frame fusion polynucleotides by introducing randomized in-frame fusion polynucleotides into an organism, selecting for organisms with new or altered phenotypes, re-isolating the randomized in-frame fusion polynucleotides from the selected organisms, re-assembling the constituent polynucleotides of the re-isolated randomized in-frame fusion polynucleotides into new collections of randomized in-frame fusion polynucleotides, and repeating the selection for organisms with new or altered phenotypes.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: September 18, 2018
    Assignee: PRIMORDIAL GENETICS INC.
    Inventor: Helge Zieler
  • Patent number: 9758810
    Abstract: Provided herein are methods for identifying centromeres and centromeres identified by such methods. Centromeres of organisms such as algae, fungi, and protists can be used, for example, for constructing artificial chromosomes and cells containing such artificial chromosomes.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: September 12, 2017
    Assignee: Synthetic Genomics, Inc.
    Inventors: Helge Zieler, Robert Christopher Brown, Toby Howard Richardson, Douglas Gillette Smith
  • Publication number: 20170218033
    Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to obtain desirable phenotypic changes that modulate tolerance to stress, thus creating novel characteristics of the transformed organism.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 3, 2017
    Inventors: Helge ZIELER, Sabrina GERMAN, Animesh RAY, Biranchi Narayan PATRA
  • Publication number: 20160326521
    Abstract: The present invention relates to compositions involving randomized in-frame fusion polynucleotides and their introduction into a host organism to identify desirable phenotypic changes. The present invention further relates to methods of generating these randomized in-frame fusion polynucleotides by introducing randomized in-frame fusion polynucleotides into an organism, selecting for organisms with new or altered phenotypes, re-isolating the randomized in-frame fusion polynucleotides from the selected organisms, re-assembling the constituent polynucleotides of the re-isolated randomized in-frame fusion polynucleotides into new collections of randomized in-frame fusion polynucleotides, and repeating the selection for organisms with new or altered phenotypes.
    Type: Application
    Filed: January 9, 2015
    Publication date: November 10, 2016
    Inventor: Helge ZIELER
  • Patent number: 9200291
    Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to identify desirable phenotypic changes that disrupt or alter existing genetic or biochemical mechanisms or pathways, thus creating novel characteristics of the transformed organism. Methods for using the compositions for increasing diversity within populations of organisms are also presented.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: December 1, 2015
    Inventor: Helge Zieler
  • Publication number: 20150337321
    Abstract: The present invention provides for the nucleic acid sequences of plant centromeres. This will permit construction of stably inherited recombinant DNA constructs and minichromosomes which can serve as vectors for the construction of transgenic plant and animal cells.
    Type: Application
    Filed: May 29, 2015
    Publication date: November 26, 2015
    Inventors: Jennifer M. Mach, Helge Zieler, RongGuan Jin, Kevin Keith, Gregory P. Copenhaver, Daphne Preuss
  • Publication number: 20150329853
    Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to identify desirable phenotypic changes that disrupt or alter existing genetic or biochemical mechanisms or pathways, thus creating novel characteristics of the transformed organism. Methods for using the compositions for increasing diversity within populations of organisms are also presented.
    Type: Application
    Filed: December 19, 2013
    Publication date: November 19, 2015
    Inventor: Helge ZIELER
  • Patent number: 8759086
    Abstract: The present invention provides methods of doing business and providing services. For example, methods of increasing the revenue of crops are provided. To this end, the method includes the use of a nucleic acid sequences of plant centromeres. This will permit construction of stably inherited recombinant DNA constructs and mini chromosomes which can serve as vectors for the construction of transgenic plant and animal cells.
    Type: Grant
    Filed: February 2, 2007
    Date of Patent: June 24, 2014
    Assignee: University of Chicago
    Inventors: Jennifer M. Mach, Gregory P. Copenhaver, Helge Zieler, Kevin Keith, Daphne Preuss, RongGuan Jin
  • Publication number: 20140170708
    Abstract: The present invention provides compositions comprising randomized in-frame fusion polynucleotides and methods for introducing them into a host organism to identify desirable phenotypic changes that disrupt or alter existing genetic or biochemical mechanisms or pathways, thus creating novel characteristics of the transformed organism. Methods for using the compositions for increasing diversity within populations of organisms are also presented.
    Type: Application
    Filed: December 19, 2013
    Publication date: June 19, 2014
    Inventor: Helge ZIELER
  • Patent number: 8729341
    Abstract: The invention is generally related to methods of generating plants transformed with novel autonomous mini-chromosomes. Mini-chromosomes with novel compositions and structures are used to transform plants cells which are in turn used to generate the plant. Methods for generating the plant include methods for delivering the mini-chromosome into plant cell to transform the cell, methods for selecting the transformed cell, and methods for isolating plants transformed with the mini-chromosome. Plants generated in the present invention contain novel genes introduced into their genome by integration into existing chromosomes.
    Type: Grant
    Filed: February 23, 2005
    Date of Patent: May 20, 2014
    Assignees: University of Chicago, Chromatin Inc.
    Inventors: Helge Zieler, James Jin, Jennifer M. Mach, Gary W. Rudgers, Daphne Preuss, Mich B. Hein, Gregory P. Copenhaver, Kevin Keith
  • Patent number: 8614089
    Abstract: The invention is generally related to methods of generating plants transformed with novel autonomous mini-chromosomes. Mini-chromosomes with novel compositions and structures are used to transform plants cells which are in turn used to generate the plant. Methods for generating the plant include methods for delivering the mini-chromosome into plant cell to transform the cell, methods for selecting the transformed cell, and methods for isolating plants transformed with the mini-chromosome. Plants generated in the present invention contain novel genes introduced into their genome by integration into existing chromosomes.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: December 24, 2013
    Assignee: Chromatin, Inc.
    Inventors: Helge Zieler, Gary W. Rudgers, Gregory P. Copenhaver, Daphne Preuss, Michael H. Pauly